News > Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment

Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment

The Free Press Journal | 05/04/2021 08:06 PM | Click to read full article

Zydus Cadila on Monday informed that it has sought approval of the DGCI for using its hepatitis drug for the treatment of coronavirus.

"In what could be a breakthrough in the disease management of COVID-19, the interim results indicate that PegIFN when administered early on, could help patients recover faster".

-